Dose-Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 747-754

  Gulliford, Sarah L ^a   Foo, Kerwyn ^b   Morgan, Rachel C ^c   Aird, Edwin G ^d   Bidmead, A Margaret ^a   Critchley, Helen ^e   Evans, Philip M ^a   Gianolini, Stefano ^f   Mayles, W Philip ^g   Moore, A Rollo ^a   Sánchez Nieto, Beatriz ^h   Partridge, Mike ^a   Sydes, Matthew R ^c   Webb, Steve ^a   Dearnaley, David P ⁱ  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b WOLLONGONG HOSPITAL   (Australia)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d MOUNT VERNON HOSPITAL   (United Kingdom)

^e AWE   (United Kingdom)

^f TOMOTHERAPY INC   (United States)

^g CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^h UNIVERSIDAD DEL DESARROLLO   (Chile)

ⁱ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

dose volume constraints; late toxicity; Prostate radiotherapy; rectal complications

Indexed keywords

DOSE DISTRIBUTIONS; DOSE LEVELS; DOSE-VOLUME; DOSE-VOLUME ANALYSIS; DOSE-VOLUME CONSTRAINTS; HIGH DOSE; NORMAL TISSUE; ODDS RATIOS; PROSTATE CANCERS; PROSTATE RADIOTHERAPY; RADICAL RADIOTHERAPY; RANDOMIZED TRIAL; RECTAL TOXICITY; SIDE EFFECT; TREATMENT PLANS;

RADIOTHERAPY;

TOXICITY;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RECTUM DISEASE; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; TREATMENT PLANNING;

DOSE-RESPONSE RELATIONSHIP, RADIATION; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; ODDS RATIO; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RECTAL DISEASES; RECTUM;

EID: 76049095874     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.025     Document Type: Article

References (33)

1. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 67-74
2. Al Mamgani A., Heemsbergen W.D., Peeters S.T., et al. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int J Radiat Oncol Biol Phys 73 (2008) 685-691
3. Dearnaley D.P., Hall E., Lawrence D., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92 (2005) 488-498
4. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 8 (2007) 475-487
5. Boersma L.J., van den B.M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
6. Cozzarini C., Fiorino C., Ceresoli G.L., et al. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). Int J Radiat Oncol Biol Phys 55 (2003) 688-694
7. Fiorino C., Cozzarini C., Vavassori V., et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: Analysis of a large group of patients pooled from three institutions. Radiother Oncol 64 (2002) 1-12
8. Koper P.C., Heemsbergen W.D., Hoogeman M.S., et al. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1072-1082
9. Peeters S.T., Lebesque J.V., Heemsbergen W.D., et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
10. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer: II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
11. Sydes M.R., Stephens R.J., Moore A.R., et al. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): Methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer. Radiother Oncol 72 (2004) 199-211
12. Dearnaley D.P., Sydes M.R., Langley R.E., et al. The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397). Radiother Oncol 83 (2007) 31-41
13. Greco C., Mazzetta C., Cattani F., et al. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. Radiother Oncol 69 (2003) 215-222
14. Fiorino C., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 953-962
15. Wachter S., Gerstner N., Goldner G., et al. Rectal sequelae after conformal radiotherapy of prostate cancer: Dose-volume histograms as predictive factors. Radiother Oncol 59 (2001) 65-70
16. Akimoto T., Muramatsu H., Takahashi M., et al. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding. Int J Radiat Oncol Biol Phys 60 (2004) 1033-1039
17. Tucker S.L., Cheung R., Dong L., et al. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 353-365
18. Denham J.W., O'Brien P.C., Dunstan R.H., et al. Is there more than one late radiation proctitis syndrome?. Radiother Oncol 51 (1999) 43-53
19. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: A new understanding to improve management of symptomatic patients. Lancet Oncol 8 (2007) 1007-1017
20. Skala M., Rosewall T., Dawson L., et al. Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 690-698
21. Fiorino C., Fellin G., Rancati T., et al. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: Preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys 70 (2008) 1130-1137
22. Vargas C., Martinez A., Kestin L.L., et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1297-1308
23. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
24. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1314-1321
25. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
26. Khoo V.S., and Dearnaley D.P. Question of dose, fractionation and technique: Ingredients for testing hypofractionation in prostate cancer-The CHHiP trial. Clin Oncol (R Coll Radiol) 20 (2008) 12-14
27. Mangar S.A., Sydes M.R., Tucker H.L., et al. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: Using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397). Radiother Oncol 80 (2006) 355-362
28. Pilepich M.V., Krall J.M., Sause W.T., et al. Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate-Analysis of RTOG study 75-06. Int J Radiat Oncol Biol Phys 13 (1987) 351-357
29. LENT-SOMA tables. Radiother Oncol 35 (1995) 17-60
30. Litwin M.S., Hays R.D., Fink A., et al. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 36 (1998) 1002-1012
31. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
32. Bauman G., and Rodrigues G. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962). Int J Radiat Oncol Biol Phys 59 (2004) 912-914
33. Elliott R., Burnet N., Dunning A., et al. Radiosensitivity, radiogenomics and RAPPER. Clin Oncol (R Coll Radiol) 19 (2008) S15